The latest update is out from Aptose Biosciences ( (TSE:APS) ).

Acute myeloid leukemia (AML) cells under the microscope, in purple. There is a serious need for finding better ways to treat AML that comes back after initial treatment. Chimeric antigen receptor (CAR ...

Detailed price information for Aptose Biosciences Inc (APTOF) from The Globe and Mail including charting and trades.

The overall 5-year relative survival rate for AML is about 30%, but this number is an estimate based on a large group of people and does not predict individual outcomes. Younger people with AML tend ...

Acute myeloid leukemia (AML) is a cancer that occurs in the blood and bone marrow. In its early stages, the symptoms of AML may resemble the flu, and you may have a fever and fatigue. Treatment for ...